托吡酯联合氟桂利嗪预防偏头痛的临床观察(3)
 |
| 第1页 |
参见附件。
[5] Lo YL， Lum SY， Fook-Chong S， et al. A pilot study of topiramate dosages for migraine prophylaxis in an Asian population. J Headache Pain. 2010；11：175–178
[6] Taylor FR. Weight Change Associated with the Use of Migraine-Preventive Medications. Clinical Therapeutics. 2008；30.1069-1080
[7] Ho LL， Patrick K， Howan L， et al. Topiramate for Migraine Prophylaxis Among Chinese Population. Headache， 2007，47：616-619.
[8] Ashtari F， Shaygannejad V， Akbari M. A double-blind， randomized trial of low-dose topiramate vs propanolol in migraine prophylaxis. Acta Neurol Scand. 2008；118：301–305
[9] Pascual J， Leira R， Lainez JM. Combined therapy for migraine prevention？ Clinical experience with a b-blocker plus sodium valproate in 52 resistant migraine patients. Cephalalgia. 2003；23：961–2
[10] Headache Classification Subcommittee of the International Headache Society. Cephalalgia 2004；24(1).
[11] Pascual J， Lainez M J.A ， Leira R. Bending the Rule of Monotherapy for Migraine Prevention？ Headache.2005；45：748-750
[12] Edwards CL， Fillingimc RB， Keefe F. Race， ethnicity and clinical trials in migraine therapy. Neuroepidemiology 1987；6：178-185
您现在查看是摘要介绍页，详见PDF附件。